February 8, 2018
Novartis to update plaque psoriasis inhibitor Cosentyx
Novartis got an approval from the USFDA for a label update for its plaque psoriasis inhibitor Cosentyx (secukinumab).
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
February 8, 2018
Circassia reaches new customers in USA through Vizient
Circassia Pharmaceuticals has received a multi-year Innovative Technology contract for its Niox Vero asthma management products from Vizient.
February 8, 2018
Pharmapack Europe Award Winners 2018
Pharmapack Europe announced the winners of the much celebrated 2018 Pharmapack Awards. Due to the outstanding quality of entries, six worthy…
February 7, 2018
Sobi nets deal with Republic of Ireland to provide its therapies for haemophilia
Republic of Ireland’s Health Service Executive (HSE) and Sobi have signed a supply deal to offer people with with haemophilia haemophilia…
February 7, 2018
Form of vitamin B3 shows improvements in treating Alzheimer’s – on mouse model
Alzheimer’s disease can be with prevended neurological damage and improved cognitive and physical function with the supplement nicotinamide riboside (NR)…
February 6, 2018
Idorsia six months after demerger from Actelion posts €12M net loss, announces investing in pipeline and OPEX of €336M in 2018
Idorsia Ltd has made meaningful collaboration with industry leaders in the six and a half months since the demerger from…
February 5, 2018
Bristol-Myers Squibb reports $2.3B net loss Q4 2017, compared to net earnings of $894M in 2016
The fourth quarter and full year of 2017 Bristol-Myers Squibb were highlighted by sales for Opdivo and Eliquis, in addition to regulatory and…
February 5, 2018
Premaitha gets IONA test approval in Brasil
Premaitha Health has announced that the IONA test has been approved by Brazil’s regulatory authority, Agência Nacional de Vigilância Sanitária…
February 5, 2018
Alexion Pharmaceuticals welcomes new board member from data and analytics company
Alexion Pharmaceuticals has adde Judith A. Reinsdorf to its Board of Directors.
February 5, 2018
Canadian cannabis derivatives producer Emblem Corp’s founder leaves board of directors
Emblem Corp, licensed producer and distributor of medical cannabis and cannabis derivatives in Canada, said Monday that that its director…